Browse
We’re here to help

Find guidance on Author Services

Login | Register

Login
Register

Cart Add to Cart

Search
Browse
We’re here to help

Find guidance on Author Services

Home
All Journals
Expert Opinion on Pharmacotherapy
List of Issues
Volume 8, Issue 3

Expert Opinion on Pharmacotherapy

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

About this journalAbout

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Register a free Taylor & Francis Online account today to boost your research and gain these benefits:

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Register now or learn more

Expert Opinion on Pharmacotherapy, Volume 8, Issue 3 (2007)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Pharmacotherapy, Volume 8, Issue 3 (2007)

See all volumes and issues

Vol 25, 2024 Vol 24, 2023 Vol 23, 2022 Vol 22, 2021 Vol 21, 2020 Vol 20, 2019 Vol 19, 2018 Vol 18, 2017 Vol 17, 2016 Vol 16, 2015 Vol 15, 2014 Vol 14, 2013 Vol 13, 2012 Vol 12, 2011 Vol 11, 2010 Vol 10, 2009 Vol 9, 2008 Volume 8, 2007 Vol 7, 2006 Vol 6, 2005 Vol 5, 2004 Vol 4, 2003 Vol 3, 2002 Vol 2, 2001 Vol 1, 1999-2000

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Editorial

Article

Editorial commentary on fixed combination isosorbide dinitrate/hydralazine for nitric-oxide-enhancing therapy in heart failure

Franciosa JA: Fixed combination isosorbide dinitrate/hydralazine for nitric-oxide-enhancing therapy in heart failure. Expert Opin.Pharmacother. (2006) 7(18):2521-2531.

John M Flack

Pages: 275-277

Published online: 01 Feb 2007

AbstractforEditorial commentary on fixed combination isosorbide dinitrate/hydralazine for nitric-oxide-enhancing therapy in heart failure | Full Text | References | PDF (49.4 KB)

46 Views
4 CrossRef citations
0Altmetric

Review

Article

Cardiovascular risk in women: the impact of hormone replacement therapy and prospects for new therapeutic approaches

Helen Jeanes, David Newby & Gillian A Gray

Pages: 279-288

Published online: 01 Feb 2007

AbstractforCardiovascular risk in women: the impact of hormone replacement therapy and prospects for new therapeutic approaches | Full Text | References | PDF (171.8 KB)

80 Views
15 CrossRef citations
0Altmetric

Article

β-blocker therapy of heart failure: an update

Marco Metra, Savina Nodari, Tania Bordonali, Patrizia Milani, Francesco Fracassi & Livio Dei Cas

Pages: 289-298

Published online: 01 Feb 2007

Abstractforβ-blocker therapy of heart failure: an update | Full Text | References | PDF (121.6 KB)

142 Views
3 CrossRef citations
0Altmetric

Article

New physiopathological and therapeutic approaches to diverticular disease of the colon

Antonio Tursi

Pages: 299-307

Published online: 01 Feb 2007

AbstractforNew physiopathological and therapeutic approaches to diverticular disease of the colon | Full Text | References | PDF (111.6 KB)

158 Views
49 CrossRef citations
0Altmetric

Article

Skeletal bone diseases impact the periodontium: a review of bisphosphonate therapy

Leena Palomo, James Liu & Nabil F Bissada

Pages: 309-315

Published online: 01 Feb 2007

AbstractforSkeletal bone diseases impact the periodontium: a review of bisphosphonate therapy | Full Text | References | PDF (102.9 KB)

205 Views
11 CrossRef citations
0Altmetric

Article

Skin surgery in children: local anaesthesia and sedation techniques

Li-Fang Yeo, Lawrence F Eichenfield & Yuin-Chew Chan

Pages: 317-327

Published online: 01 Feb 2007

AbstractforSkin surgery in children: local anaesthesia and sedation techniques | Full Text | References | PDF (121.1 KB)

152 Views
11 CrossRef citations
0Altmetric

Article

Treatment and dosing of Helicobacter pylori infection: when pharmacology meets clinic

Gerhard Treiber, Peter Malfertheiner & Ulrich Klotz

Pages: 329-350

Published online: 01 Feb 2007

AbstractforTreatment and dosing of Helicobacter pylori infection: when pharmacology meets clinic | Full Text | References | PDF (248.5 KB)

204 Views
19 CrossRef citations
0Altmetric

Drug Evaluation

Article

Motexafin gadolinium in the treatment of brain metastases

Gregory M Richards & Minesh P Mehta

Pages: 351-359

Published online: 01 Feb 2007

AbstractforMotexafin gadolinium in the treatment of brain metastases | Full Text | References | PDF (112.4 KB)

219 Views
26 CrossRef citations
0Altmetric

Article

Nesiritide: a reappraisal of efficacy and safety

Sanjiv J Shah & John R Teerlink

Pages: 361-369

Published online: 01 Feb 2007

AbstractforNesiritide: a reappraisal of efficacy and safety | Full Text | References | PDF (127.8 KB)

54 Views
8 CrossRef citations
0Altmetric

Article

Efavirenz/emtricitabine/tenofovir disoproxil fumarate fixed-dose combination: first-line therapy for all?

Miguel Goicoechea & Brookie Best

Pages: 371-382

Published online: 01 Feb 2007

AbstractforEfavirenz/emtricitabine/tenofovir disoproxil fumarate fixed-dose combination: first-line therapy for all? | Full Text | References | PDF (139.4 KB)

270 Views
25 CrossRef citations
0Altmetric

Key Paper Evaluation

Article

Is fingolimod an advancement in the treatment of multiple sclerosis?

KAPPOS L, ANTEL J, COMI G. et al.: Oral fingolimod (FTY720) for relapsing multiple sclerosis. N. Engl. J. Med. (2006) 355:1124-1140.

Sheila A Doggrell

Pages: 383-386

Published online: 01 Feb 2007

AbstractforIs fingolimod an advancement in the treatment of multiple sclerosis? | Full Text | References | PDF (63.1 KB)

183 Views
3 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Advances with janus kinase inhibitors for the treatment of myeloproliferative neoplasms: an update of the literature

Anthony M. Hunter et al.

Review Article | Published online: 27 Jul 2024

PSMA-based therapeutics for prostate cancer

Panagiotis Velissarios Stamatakos et al.

Review Article | Published online: 26 Jul 2024

Examining linaclotide for the treatment of chronic idiopathic constipation

Jeff Angelo Taclob et al.

Review Article | Published online: 26 Jul 2024

What is the impact of anemia pharmacotherapy on chronic kidney disease progression?

Hanna T. Webb et al.

Editorial | Published online: 24 Jul 2024

Free Access

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Pharmacotherapy (Vol.8, Iss.3, 2007)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?